Your browser doesn't support javascript.
loading
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version).
Bouchi, Ryotaro; Kondo, Tatsuya; Ohta, Yasuharu; Goto, Atsushi; Tanaka, Daisuke; Satoh, Hiroaki; Yabe, Daisuke; Nishimura, Rimei; Harada, Norio; Kamiya, Hideki; Suzuki, Ryo; Yamauchi, Toshimasa.
Afiliação
  • Bouchi R; Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kondo T; Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Kumamoto, Japan.
  • Ohta Y; Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Goto A; Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan.
  • Tanaka D; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Satoh H; Department of Diabetes and Endocrinology, Juntendo University Urayasu Hospital, Chiba, Japan.
  • Yabe D; Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Nishimura R; Division of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine, Tokyo, Japan.
  • Harada N; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kamiya H; Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
  • Suzuki R; Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo, Japan.
  • Yamauchi T; Department of Diabetes and Metabolic Diseases, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
J Diabetes Investig ; 2024 Jul 11.
Article em En | MEDLINE | ID: mdl-38988282
ABSTRACT
This algorithm was issued for the appropriate use of drugs for the treatment of type 2 diabetes mellitus in Japan. The revisions include safety considerations, fatty liver disease as a comorbidity to be taken into account and the position of tirzepatide.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Diabetes Investig Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Diabetes Investig Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão